Cargando…
Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients
Sphingolipids are characterized by a broad range of bioactive properties. Particularly, the development of insulin resistance, a major pathophysiological hallmark of Type 2 Diabetes mellitus (T2D), has been linked to ceramide signaling. Since vitamin D supplementation may slow down T2D progression b...
Autores principales: | Koch, Alexander, Grammatikos, Georgios, Trautmann, Sandra, Schreiber, Yannick, Thomas, Dominique, Bruns, Franziska, Pfeilschifter, Josef, Badenhoop, Klaus, Penna-Martinez, Marissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536020/ https://www.ncbi.nlm.nih.gov/pubmed/28714882 http://dx.doi.org/10.3390/ijms18071532 |
Ejemplares similares
-
Vitamin D in Type 2 Diabetes: Genetic Susceptibility and the Response
to Supplementation
por: Klahold, Edith, et al.
Publicado: (2020) -
Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation
por: Mücke, Victoria Therese, et al.
Publicado: (2018) -
Inherited Variation in Vitamin D Genes and Type 1 Diabetes Predisposition
por: Penna-Martinez, Marissa, et al.
Publicado: (2017) -
C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma
por: Wilhelm, Raphael, et al.
Publicado: (2021) -
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine
por: Brunkhorst, R., et al.
Publicado: (2015)